Endoscopic Ultrasonographic Evaluation of Therapeutic Intervention for Non-Alcoholic Early Chronic Pancreatitis

被引:0
|
作者
Ohtsubo, Koushiro [1 ]
Mouri, Hisatsugu [1 ]
Yamashita, Kaname [1 ]
Toshima, Fumihito [2 ]
Inoue, Dai [2 ]
Gabata, Toshifumi [2 ]
Watanabe, Hiroyuki [3 ]
Yano, Seiji [1 ]
机构
[1] Kanazawa Univ, Canc Res Inst, Div Med Oncol, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan
[2] Kanazawa Univ, Dept Radiol, Kanazawa, Ishikawa, Japan
[3] Fukui Saiseikai Hosp, Dept Internal Med, Fukui, Japan
来源
JOURNAL OF THE PANCREAS | 2016年 / 17卷 / 06期
关键词
Pancreatitis; Chronic; Endosonography; Cholangiopancreatography; Magnetic Resonance; Camostat; Pancrelipase;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives The concept of early chronic pancreatitis was initially described in the 2009 Japanese diagnostic criteria for chronic pancreatitis. However, the clinical features of non-alcoholic early chronic pancreatitis have not been defined. The aim of this study is to elucidate the clinical features of non-alcoholic early chronic pancreatitis. Methods Thirteen patients, two men and 11 women were diagnosed with non-alcoholic early chronic pancreatitis by revised 2009 criteria. Their clinical features, including their radiologic and endoscopic ultrasonographic findings and clinical courses, were retrospectively reviewed. Results Ten (77%) patients presented with back pain in addition to upper abdominal pain. Pancreatic enzymes were elevated in the sera of seven (54%) patients. EUS findings included lobularity with honeycombing in one (8%), lobularity without honeycombing in seven (54%), hyperechoic foci without shadowing in 10 (77%), strands in 13 (100%), and hyperechoic main pancreatic duct margin in 11 (85%). Neither contrast-enhanced computed tomography nor magnetic resonance imaging/magnetic resonance cholangiopancreatography showed definite abnormalities in the pancreatic parenchyma. However, magnetic resonance cholangiopancreatography showed evidence of pancreaticobiliary maljunction and pancreatic divisum in one patient each. Camostat mesilate and high titer pancreatic enzyme pancrelipase were effective for relief of pain in all the patients except for two. However, the nine patients followed up for several years showed no improvement in endoscopic ultrasonographic findings. Conclusions Endoscopic ultrasonography may be useful in diagnosing non-alcoholic early chronic pancreatitis, even though computed tomography and magnetic resonance imaging could not detect abnormalities. Medication was effective for relief of pain, but did not improve endoscopic ultrasonographic findings for non-alcoholic early chronic pancreatitis. Further investigations are necessary to identify methods to prevent non-alcoholic early chronic pancreatitis progression.
引用
收藏
页码:629 / 636
页数:8
相关论文
共 50 条
  • [31] Diagnostic and therapeutic management of non-alcoholic steatohepatitis
    Anton, Carmen
    Dimache, Mihaela
    Bistriceanu, Sandina
    Spataru, Vlad
    Hartie, Codrina
    Anton, Emil
    XXXVI NATIONAL CONGRESS OF GASTROENTEROLOGY, HEPATOLOGY AND DIGESTIVE ENDOSCOPY, 2016, : 12 - 18
  • [32] New therapeutic perspectives in non-alcoholic steatohepatitis
    Ampuero, Javier
    Sanchez-Torrijos, Yolanda
    Aguilera, Virginia
    Bellido, Francisco
    Romero-Gomez, Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (02): : 128 - 142
  • [33] OBETICHOLIC ACID FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS:AN EARLY ECONOMIC EVALUATION
    Tran, Phong
    Wong, William W. L.
    MEDICAL DECISION MAKING, 2021, 41 (04) : E28 - E28
  • [34] Evaluation of the subgingival microbiota of alcoholic and non-alcoholic individuals
    Furtado Amaral, Cristine da Silva
    da Silva-Boghossian, Carina Maciel
    Thome Leao, Anna Thereza
    Vieira Colombo, Ana Paula
    JOURNAL OF DENTISTRY, 2011, 39 (11) : 729 - 738
  • [35] Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Senavirathna, Tharani
    Shafaei, Armaghan
    Lareu, Ricky
    Balmer, Lois
    ANTIOXIDANTS, 2024, 13 (04)
  • [36] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    DIABETES, 2012, 61 : A265 - A266
  • [37] Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis Inflammatory bowel disease in pancreatitis
    Schneider, Alexander
    Hirth, Michael
    Weiss, Christel
    Weidner, Philip
    Antoni, Christoph
    Thomann, Anne
    Reindl, Wolfgang
    Ebert, Matthias P.
    Pfuetzer, Roland H.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (05): : 469 - 478
  • [38] Evaluation and management of non-alcoholic steatohepatitis
    Reid, BM
    Sanyal, AJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (11) : 1117 - 1122
  • [39] Evaluation and management of non-alcoholic steatohepatitis
    Ramesh, S
    Sanyal, AJ
    JOURNAL OF HEPATOLOGY, 2005, 42 : S2 - S12
  • [40] Src kinase as a potential therapeutic target in non-alcoholic and alcoholic steatohepatitis
    Kurniawan, Dhadhang Wahyu
    Booijink, Richell
    Jajoriya, Arun Kumar
    Dhawan, Garima
    Mishra, Divya
    Oosterhuis, Dorenda
    Argemi, Josepmaria
    Storm, Gert
    Olinga, Peter
    Bataller, Ramon
    Mohanty, Sujit Kumar
    Mishra, Durga Prasad
    Prakash, Jai
    Bansal, Ruchi
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2022, 2 (01):